Centessa Pharmaceuticals PLC (CNTA)

Ticker: CNTA Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Centessa Pharmaceuticals PLC. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Anderson Karen M. Chief People Officer Officer
Transaction date
Planned sale
Price
383.85
Quantity 3,058 -28.2%
Value US$195,250
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
212.22
Quantity 93,494 +5.0%
Value US$898,731
2.6
Weinhoff Gregory M Officer Officer
Transaction date
Proposed sale
Price
387.64
Quantity 60,490
Value US$2,131,765
Anderson Karen M. Officer Officer
Transaction date
Proposed sale
Price
28.15
Quantity 41,076
Value US$1,156,289
Anderson Karen M. Chief People Officer Officer
Transaction date
Planned sale
Price
28.10
Quantity 10,043 -13.9%
Value US$282,210
Anderson Karen M. Officer Officer
Transaction date
Proposed sale
Price
27.98
Quantity 10,043
Value US$281,003
Anderson Karen M. Chief People Officer Officer
Transaction date
Planned sale
Price
28.21
Quantity 64,768 -51.1%
Value US$1,826,969
Anderson Karen M. Officer Officer
Transaction date
Proposed sale
Price
28.21
Quantity 64,768
Value US$1,826,969
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
27.16
Quantity 11,943 -15.3%
Value US$324,336
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
26.17
Quantity 61,253 -44.0%
Value US$1,602,795
Anderson Karen M. Chief People Officer Officer
Transaction date
Planned sale
Price
27.13
Quantity 12,068 -16.3%
Value US$327,439
Anderson Karen M. Chief People Officer Officer
Transaction date
Planned sale
Price
26.15
Quantity 107,961 -59.3%
Value US$2,823,234
Anderson Karen M. Officer Officer
Transaction date
Proposed sale
Price
25.86
Quantity 120,029
Value US$3,103,950
2.6
Weinhoff Gregory M Officer Officer
Transaction date
Proposed sale
Price
27.24
Quantity 73,196
Value US$1,993,493
1.5
HUSSAIN IQBAL J Chief Legal Officer Officer
Transaction date
Sale
Price
25.15
Quantity 38,951 -40.3%
Value US$979,657
1.5
HUSSAIN IQBAL J Chief Legal Officer Officer
Transaction date
Sale
Price
25.15
Quantity 38,951 -40.3%
Value US$979,657
1.5
HUSSAIN IQBAL J Chief Legal Officer Officer
Transaction date
Sale
Price
25.01
Quantity 1,010 -1.0%
Value US$25,261
1.5
Iqbal Hussain Officer Officer
Transaction date
Proposed sale
Price
25.50
Quantity 39,961
Value US$1,019,005
2.1
Saurabh Saha Former Officer Officer
Transaction date
Proposed sale
Price
22.87
Quantity 2,300,000
Value US$52,601,000
2.1
Saurabh Saha Previous Officer Officer
Transaction date
Proposed sale
Price
24.30
Quantity 2,500,000
Value US$60,750,000
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
29.30
Quantity 10,000
Value US$293,000
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
29.21
Quantity 2,568 -1.4%
Value US$75,005
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
28.70
Quantity 7,432 -3.9%
Value US$213,284
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 10,000
Value US$300,000
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
30.00
Quantity 10,000 -5.0%
Value US$300,000
1.6
Bush Tia L Chief Technology & Quality Ofc Officer
Transaction date
Planned sale
Price
28.00
Quantity 40,000 -24.8%
Value US$1,120,000
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
27.64
Quantity 6,000 -5.4%
Value US$165,835
1.6
Bush Tia L Officer Officer
Transaction date
Proposed sale
Price
28.00
Quantity 40,000
Value US$1,120,000
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
27.74
Quantity 6,000
Value US$166,440
1.6
Bush Tia L Chief Technology & Quality Ofc Officer
Transaction date
Planned sale
Price
26.00
Quantity 40,000 -24.8%
Value US$1,040,000
1.6
Bush Tia L Officer Officer
Transaction date
Proposed sale
Price
26.00
Quantity 40,000
Value US$1,040,000
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 8,000
Value US$200,000
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 8,000
Value US$200,000
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
25.00
Quantity 8,000 -4.0%
Value US$200,000
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
22.41
Quantity 6,000 -5.4%
Value US$134,439
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
22.61
Quantity 6,000
Value US$135,660
1.6
Bush Tia L Officer Officer
Transaction date
Proposed sale
Price
24.00
Quantity 35,000
Value US$840,000
1.6
Bush Tia L Chief Technology & Quality Ofc Officer
Transaction date
Planned sale
Price
24.00
Quantity 35,000 -22.4%
Value US$840,000
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
22.06
Quantity 8,172
Value US$180,274
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
22.02
Quantity 742 -0.4%
Value US$16,340
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
21.33
Quantity 7,430 -3.6%
Value US$158,506
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
21.81
Quantity 6,000
Value US$130,860
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
21.85
Quantity 6,000 -5.4%
Value US$131,101
1.6
Bush Tia L Chief Technology & Quality Ofc Officer
Transaction date
Planned sale
Price
22.00
Quantity 25,000 -17.1%
Value US$550,000
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
22.00
Quantity 20,000 -16.0%
Value US$440,000
1.6
Bush Tia L Officer Officer
Transaction date
Proposed sale
Price
22.00
Quantity 25,000
Value US$550,000
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
22.00
Quantity 20,000
Value US$440,000
1.6
Bush Tia L Chief Technology & Quality Ofc Officer
Transaction date
Planned sale
Price
20.00
Quantity 24,792 -16.9%
Value US$495,840
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
20.01
Quantity 20,000 -16.0%
Value US$400,102
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
20.00
Quantity 7,000 -3.3%
Value US$140,000
1.6
Bush Tia L Officer Officer
Transaction date
Proposed sale
Price
20.00
Quantity 24,792
Value US$495,840
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
20.00
Quantity 7,000
Value US$140,000
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
20.01
Quantity 20,000
Value US$400,102
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
17.23
Quantity 6,000
Value US$103,380
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
17.23
Quantity 6,000 -5.4%
Value US$103,380
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
15.37
Quantity 8,322
Value US$127,909
2.6
Weinhoff Gregory M Officer Officer
Transaction date
Proposed sale
Price
15.56
Quantity 10,000
Value US$155,598
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
15.56
Quantity 10,000 -7.6%
Value US$155,598
2.1
SAHA SAURABH Officer; CEO Officer
Transaction date
Proposed sale
Price
15.99
Quantity 55,000
Value US$879,450
2.1
SAHA SAURABH Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
15.92
Quantity 55,000 -19.9%
Value US$875,600
2.6
CHAO DAVID M Officer Officer
Transaction date
Proposed sale
Price
16.00
Quantity 5,000
Value US$80,000
2.6
CHAO DAVID M Officer Officer
Transaction date
Proposed sale
Price
14.92
Quantity 10,000
Value US$149,182
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
14.93
Quantity 6,000 -5.4%
Value US$89,567
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
14.93
Quantity 6,000
Value US$89,567
2.6
Weinhoff Gregory M Officer Officer
Transaction date
Proposed sale
Price
14.00
Quantity 10,000
Value US$140,000
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
13.86
Quantity 10,000 -7.6%
Value US$138,642
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
14.00
Quantity 15,000
Value US$210,000
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
14.00
Quantity 15,000 -6.5%
Value US$210,000
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
14.02
Quantity 12,000 -10.2%
Value US$168,218
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
14.02
Quantity 12,000
Value US$168,218
2.6
CHAO DAVID M Officer Officer
Transaction date
Proposed sale
Price
12.87
Quantity 10,000
Value US$128,650
2.1
SAHA SAURABH Officer; CEO Officer
Transaction date
Proposed sale
Price
12.87
Quantity 55,000
Value US$707,575
2.1
SAHA SAURABH Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
12.63
Quantity 55,000 -19.9%
Value US$694,826
2.6
Weinhoff Gregory M Officer Officer
Transaction date
Proposed sale
Price
12.82
Quantity 10,000
Value US$128,225
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
12.82
Quantity 10,000 -7.6%
Value US$128,225
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-27 2026-03-26 PlS Planned sale

Chief People Officer

Officer
3,058 -28.2%
383.85
US$195,250
3,058 -28.2% 383.85 US$195,250
2026-03-26 2026-03-26 PlS Planned sale

Chief Business Officer

Officer
93,494 +5.0%
212.22
US$898,731
93,494 +5.0% 212.22 US$898,731
2026-03-26 2026-03-26 PrS Proposed sale

Officer

Officer
60,490
387.64
US$2,131,765
60,490 387.64 US$2,131,765
2026-03-26 2026-03-26 PrS Proposed sale

Officer

Officer
41,076
28.15
US$1,156,289
41,076 28.15 US$1,156,289
2026-03-18 2026-03-17 PlS Planned sale

Chief People Officer

Officer
10,043 -13.9%
28.10
US$282,210
10,043 -13.9% 28.10 US$282,210
2026-03-17 2026-03-17 PrS Proposed sale

Officer

Officer
10,043
27.98
US$281,003
10,043 27.98 US$281,003
2026-03-18 2026-03-16 PlS Planned sale

Chief People Officer

Officer
64,768 -51.1%
28.21
US$1,826,969
64,768 -51.1% 28.21 US$1,826,969
2026-03-16 2026-03-16 PrS Proposed sale

Officer

Officer
64,768
28.21
US$1,826,969
64,768 28.21 US$1,826,969
2026-03-13 2026-03-13 PlS Planned sale

Chief Business Officer

Officer
11,943 -15.3%
27.16
US$324,336
11,943 -15.3% 27.16 US$324,336
2026-03-13 2026-03-13 PlS Planned sale

Chief Business Officer

Officer
61,253 -44.0%
26.17
US$1,602,795
61,253 -44.0% 26.17 US$1,602,795
2026-03-13 2026-03-13 PlS Planned sale

Chief People Officer

Officer
12,068 -16.3%
27.13
US$327,439
12,068 -16.3% 27.13 US$327,439
2026-03-13 2026-03-13 PlS Planned sale

Chief People Officer

Officer
107,961 -59.3%
26.15
US$2,823,234
107,961 -59.3% 26.15 US$2,823,234
2026-03-13 2026-03-13 PrS Proposed sale

Officer

Officer
120,029
25.86
US$3,103,950
120,029 25.86 US$3,103,950
2026-03-13 2026-03-13 PrS Proposed sale

Officer

Officer
73,196
27.24
US$1,993,493
73,196 27.24 US$1,993,493
2026-02-03 2026-02-02 S Sale

Chief Legal Officer

Officer
38,951 -40.3%
25.15
US$979,657
38,951 -40.3% 25.15 US$979,657
2026-02-03 2026-02-02 S Sale

Chief Legal Officer

Officer
38,951 -40.3%
25.15
US$979,657
38,951 -40.3% 25.15 US$979,657
2026-02-03 2026-01-30 S Sale

Chief Legal Officer

Officer
1,010 -1.0%
25.01
US$25,261
1,010 -1.0% 25.01 US$25,261
2026-01-30 2026-01-30 PrS Proposed sale

Officer

Officer
39,961
25.50
US$1,019,005
39,961 25.50 US$1,019,005
2026-01-21 2026-01-21 PrS Proposed sale

Former Officer

Officer
2,300,000
22.87
US$52,601,000
2,300,000 22.87 US$52,601,000
2026-01-02 2026-01-02 PrS Proposed sale

Previous Officer

Officer
2,500,000
24.30
US$60,750,000
2,500,000 24.30 US$60,750,000
2025-12-09 2025-12-09 PrS Proposed sale

Officer

Officer
10,000
29.30
US$293,000
10,000 29.30 US$293,000
2025-12-09 2025-12-09 PlS Planned sale

President, Orexin Program

Officer
2,568 -1.4%
29.21
US$75,005
2,568 -1.4% 29.21 US$75,005
2025-12-09 2025-12-09 PlS Planned sale

President, Orexin Program

Officer
7,432 -3.9%
28.70
US$213,284
7,432 -3.9% 28.70 US$213,284
2025-12-08 2025-12-08 PrS Proposed sale

Officer

Officer
10,000
30.00
US$300,000
10,000 30.00 US$300,000
2025-12-08 2025-12-08 PlS Planned sale

President, Orexin Program

Officer
10,000 -5.0%
30.00
US$300,000
10,000 -5.0% 30.00 US$300,000
2025-11-18 2025-11-17 PlS Planned sale

Chief Technology & Quality Ofc

Officer
40,000 -24.8%
28.00
US$1,120,000
40,000 -24.8% 28.00 US$1,120,000
2025-11-18 2025-11-17 PlS Planned sale

General Counsel

Officer
6,000 -5.4%
27.64
US$165,835
6,000 -5.4% 27.64 US$165,835
2025-11-17 2025-11-17 PrS Proposed sale

Officer

Officer
40,000
28.00
US$1,120,000
40,000 28.00 US$1,120,000
2025-11-17 2025-11-17 PrS Proposed sale

Officer

Officer
6,000
27.74
US$166,440
6,000 27.74 US$166,440
2025-11-13 2025-11-12 PlS Planned sale

Chief Technology & Quality Ofc

Officer
40,000 -24.8%
26.00
US$1,040,000
40,000 -24.8% 26.00 US$1,040,000
2025-11-12 2025-11-12 PrS Proposed sale

Officer

Officer
40,000
26.00
US$1,040,000
40,000 26.00 US$1,040,000
2025-10-27 2025-10-27 PrS Proposed sale

Officer

Officer
8,000
25.00
US$200,000
8,000 25.00 US$200,000
2025-10-27 2025-10-27 PrS Proposed sale

Officer

Officer
8,000
25.00
US$200,000
8,000 25.00 US$200,000
2025-10-27 2025-10-27 PlS Planned sale

President, Orexin Program

Officer
8,000 -4.0%
25.00
US$200,000
8,000 -4.0% 25.00 US$200,000
2025-10-16 2025-10-15 PlS Planned sale

General Counsel

Officer
6,000 -5.4%
22.41
US$134,439
6,000 -5.4% 22.41 US$134,439
2025-10-15 2025-10-15 PrS Proposed sale

Officer

Officer
6,000
22.61
US$135,660
6,000 22.61 US$135,660
2025-09-24 2025-09-24 PrS Proposed sale

Officer

Officer
35,000
24.00
US$840,000
35,000 24.00 US$840,000
2025-09-24 2025-09-24 PlS Planned sale

Chief Technology & Quality Ofc

Officer
35,000 -22.4%
24.00
US$840,000
35,000 -22.4% 24.00 US$840,000
2025-09-16 2025-09-16 PrS Proposed sale

Officer

Officer
8,172
22.06
US$180,274
8,172 22.06 US$180,274
2025-09-16 2025-09-16 PlS Planned sale

President, Orexin Program

Officer
742 -0.4%
22.02
US$16,340
742 -0.4% 22.02 US$16,340
2025-09-16 2025-09-16 PlS Planned sale

President, Orexin Program

Officer
7,430 -3.6%
21.33
US$158,506
7,430 -3.6% 21.33 US$158,506
2025-09-15 2025-09-15 PrS Proposed sale

Officer

Officer
6,000
21.81
US$130,860
6,000 21.81 US$130,860
2025-09-15 2025-09-15 PlS Planned sale

General Counsel

Officer
6,000 -5.4%
21.85
US$131,101
6,000 -5.4% 21.85 US$131,101
2025-09-11 2025-09-10 PlS Planned sale

Chief Technology & Quality Ofc

Officer
25,000 -17.1%
22.00
US$550,000
25,000 -17.1% 22.00 US$550,000
2025-09-11 2025-09-10 PlS Planned sale

General Counsel

Officer
20,000 -16.0%
22.00
US$440,000
20,000 -16.0% 22.00 US$440,000
2025-09-10 2025-09-10 PrS Proposed sale

Officer

Officer
25,000
22.00
US$550,000
25,000 22.00 US$550,000
2025-09-10 2025-09-10 PrS Proposed sale

Officer

Officer
20,000
22.00
US$440,000
20,000 22.00 US$440,000
2025-09-11 2025-09-09 PlS Planned sale

Chief Technology & Quality Ofc

Officer
24,792 -16.9%
20.00
US$495,840
24,792 -16.9% 20.00 US$495,840
2025-09-11 2025-09-09 PlS Planned sale

General Counsel

Officer
20,000 -16.0%
20.01
US$400,102
20,000 -16.0% 20.01 US$400,102
2025-09-11 2025-09-09 PlS Planned sale

President, Orexin Program

Officer
7,000 -3.3%
20.00
US$140,000
7,000 -3.3% 20.00 US$140,000
2025-09-09 2025-09-09 PrS Proposed sale

Officer

Officer
24,792
20.00
US$495,840
24,792 20.00 US$495,840
2025-09-09 2025-09-09 PrS Proposed sale

Officer

Officer
7,000
20.00
US$140,000
7,000 20.00 US$140,000
2025-09-09 2025-09-09 PrS Proposed sale

Officer

Officer
20,000
20.01
US$400,102
20,000 20.01 US$400,102
2025-08-15 2025-08-15 PrS Proposed sale

Officer

Officer
6,000
17.23
US$103,380
6,000 17.23 US$103,380
2025-08-15 2025-08-15 PlS Planned sale

General Counsel

Officer
6,000 -5.4%
17.23
US$103,380
6,000 -5.4% 17.23 US$103,380
2025-07-29 2025-07-29 PrS Proposed sale

Officer

Officer
8,322
15.37
US$127,909
8,322 15.37 US$127,909
2025-07-25 2025-07-25 PrS Proposed sale

Officer

Officer
10,000
15.56
US$155,598
10,000 15.56 US$155,598
2025-07-25 2025-07-25 PlS Planned sale

Chief Business Officer

Officer
10,000 -7.6%
15.56
US$155,598
10,000 -7.6% 15.56 US$155,598
2025-07-21 2025-07-21 PrS Proposed sale

Officer; CEO

Officer
55,000
15.99
US$879,450
55,000 15.99 US$879,450
2025-07-21 2025-07-21 PlS Planned sale

Chief Executive Officer

Executive Director
55,000 -19.9%
15.92
US$875,600
55,000 -19.9% 15.92 US$875,600
2025-07-17 2025-07-17 PrS Proposed sale

Officer

Officer
5,000
16.00
US$80,000
5,000 16.00 US$80,000
2025-07-17 2025-07-15 PrS Proposed sale

Officer

Officer
10,000
14.92
US$149,182
10,000 14.92 US$149,182
2025-07-17 2025-07-15 PlS Planned sale

General Counsel

Officer
6,000 -5.4%
14.93
US$89,567
6,000 -5.4% 14.93 US$89,567
2025-07-15 2025-07-15 PrS Proposed sale

Officer

Officer
6,000
14.93
US$89,567
6,000 14.93 US$89,567
2025-06-25 2025-06-25 PrS Proposed sale

Officer

Officer
10,000
14.00
US$140,000
10,000 14.00 US$140,000
2025-06-25 2025-06-25 PlS Planned sale

Chief Business Officer

Officer
10,000 -7.6%
13.86
US$138,642
10,000 -7.6% 13.86 US$138,642
2025-06-25 2025-06-24 PrS Proposed sale

Officer

Officer
15,000
14.00
US$210,000
15,000 14.00 US$210,000
2025-06-25 2025-06-24 PlS Planned sale

President, Orexin Program

Officer
15,000 -6.5%
14.00
US$210,000
15,000 -6.5% 14.00 US$210,000
2025-06-25 2025-06-24 PlS Planned sale

General Counsel

Officer
12,000 -10.2%
14.02
US$168,218
12,000 -10.2% 14.02 US$168,218
2025-06-24 2025-06-24 PrS Proposed sale

Officer

Officer
12,000
14.02
US$168,218
12,000 14.02 US$168,218
2025-06-20 2025-06-20 PrS Proposed sale

Officer

Officer
10,000
12.87
US$128,650
10,000 12.87 US$128,650
2025-06-20 2025-06-20 PrS Proposed sale

Officer; CEO

Officer
55,000
12.87
US$707,575
55,000 12.87 US$707,575
2025-06-20 2025-06-20 PlS Planned sale

Chief Executive Officer

Executive Director
55,000 -19.9%
12.63
US$694,826
55,000 -19.9% 12.63 US$694,826
2025-05-27 2025-05-27 PrS Proposed sale

Officer

Officer
10,000
12.82
US$128,225
10,000 12.82 US$128,225
2025-05-27 2025-05-27 PlS Planned sale

Chief Business Officer

Officer
10,000 -7.6%
12.82
US$128,225
10,000 -7.6% 12.82 US$128,225